Results 81 to 90 of about 5,508,972 (143)

Fluorous Drug-Affinity Proteomics for Cancer Drug Discovery [PDF]

open access: yes, 2015
Identifying the intracellular targets of small molecules – target ID – is a major problem in chemical biology with broad application to the discovery and development of novel therapies.
Herzberg, Benjamin
core   +4 more sources

Drug target binding affinity prediction considering the interaction of molecule atom and protein subsequences

open access: yes, 2021
The identification of drug target interactions is an important task in drug discovery. To model the interaction of drug and protein, most of the computational methods of drug target affinity prediction have been proposed the global interaction between ...
Haelee Bae
core   +1 more source

Comparison Study of Computational Prediction Tools for Drug-Target Binding Affinities

open access: yesFrontiers in Chemistry, 2019
The drug development is generally arduous, costly, and success rates are low. Thus, the identification of drug-target interactions (DTIs) has become a crucial step in early stages of drug discovery.
Maha Thafar   +6 more
doaj   +1 more source

Discovery of Novel Active Diamidines as Clinical Candidates Against "Trypanosoma Evansi" Infection [PDF]

open access: yes, 2007
The animal pathogenic protozoan, Trypanosoma evansi, leads to a wasting disease in equines, cattle and camels, commonly known as Surra. It is extensively distributed geographically with a wide range of mammalian hosts and causes great economical loss ...
Gillingwater, Kirsten
core   +1 more source

The Trypanosoma brucei sphingolipid synthase, an essential enzyme and a drug target [PDF]

open access: yes, 2009
Sphingolipids are important structural components of eukaryotic membranes, in addition they and their precursors are involved in signal transduction processes.
Pan, Ssu-Ying
core  

Drug target identification in protozoan parasites.

open access: yes, 2016
INTRODUCTION Despite the fact that diseases caused by protozoan parasites represent serious challenges for public health, animal production and welfare, only a limited panel of drugs has been marketed for clinical applications.
Joachim Müller   +3 more
core   +1 more source

Epidermal growth factor receptor: Target for delivery and silencing [PDF]

open access: yes, 2008
Epidermal growth factor receptor in cancer therapy Recently, cancer research has been able to identify molecular targets that are specific for (or highly expressed by) cancer cells.
Santos Oliveira, S.   +2 more
core   +1 more source

MTAF–DTA: multi-type attention fusion network for drug–target affinity prediction

open access: yesBMC Bioinformatics
Background The development of drug–target binding affinity (DTA) prediction tasks significantly drives the drug discovery process forward. Leveraging the rapid advancement of artificial intelligence, DTA prediction tasks have undergone a transformative ...
Jinghong Sun   +4 more
doaj   +1 more source

Structure-free drug–target affinity prediction using protein and molecule language models

open access: yesJournal of Cheminformatics
Accurate prediction of drug-target affinity (DTA) is crucial for advancing drug discovery and optimizing experimental processes. Traditional DTA models often rely on handcrafted features or structural data, which can limit their generalizability and ...
Amir Hallaji Bidgoli   +2 more
doaj   +1 more source

Stereochemistry-Aware Drug-Target Affinity Prediction

open access: yesbioRxiv
Drug–target affinity (DTA) prediction is a key task in drug discovery, enabling the estimation of the interaction strength between candidate compounds and biological targets.
Santiago Ferreyra   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy